News and Events

After years of hard work, persistence and collaboration, PRRT as a permanent and national service was officially launched.  This is transformative for NET patients in NZ.  An interim service has been running at Auckland City Hospital, and The Minister of Health, Hon...

We would love to host you on campus for a special evening to recognise the work of the Translational Medicine Trust (TMT), who are winding up after completing their designated role. We will also take the opportunity to review NETwork! research and look ahead to the...

Today, the first NET patient was treated in New Zealand with PRRT (Peptide Receptor Radionuclide Therapy). This is a huge milestone for NET patient care in NZ and something we are very proud to have been a part of, led by our very own Dr Ben Lawrence and of course...

New Zealand Society for Oncology Conference 2019 was held in Wellington 25-26th October.  It was another fantastic opportunity to connect with other researchers/clinicians both from NZ and overseas, allowing us to catch up on research progress from other groups as...

In early 2016, a patient with a metastastic broncho-pulmonary NET made a direct approach to her oncologist, Dr Ben Lawrence (a principal investigator of the NETwork! team). The patient wished to donate her tumour tissues through rapid autopsy on her natural death. Her...

  Good cancer care is multidisciplinary, sub-specialized, and highly coordinated. There are hundreds of healthcare moments that impact outcome for each individual patient. Measuring every moment is impractical, but the patient journey can be distilled down to a...

The Unicorn Foundation held their annual NET Cancer Education Day on Friday 13th September at the Holiday Inn, Auckland Airport. Dr Ben Lawrence and Dr Kate Parker were thrilled to be invited to speak about neuroendocrine cancer and share some recent updates from our...

                  The 16th Annual ENETS (European Neuroendocrine Tumor Society) Conference was held last week (6-8th March 2019). As always, it was a fantastic opportunity to connect with our international collaborators,...

Cancer Care at a Crossroads Conference was held 31 January – 1 February 2019 at Te Papa in Wellington, New Zealand. Dr Ben Lawrence (NETwork! Project PI) participated in a debate with Prof Richard Sullivan (UK) around "Precision medicine is the future of cancer care"....

Our very own Dr Cherie Blenkiron with an AMRF news article for her work on Merkel Cell Carcinoma - see article link below for more.   https://www.medicalresearch.org.nz/kiwi-experts-shining-light-on-skin-cancer

This week, INCA (International Neuroendocrine Cancer Alliance) presented the poster: ‘Unmet needs in the management of neuroendocrine tumours (NETs): A global survey of patients, patient advocates and healthcare professionals’ at ESMO Munich 2018, winning the Best...

It was a true privilege to represent NET research this year at NZSO and at Queenstown Research Week (QMB Cancer Satellite).  It is always great to be updated from research colleagues around the country, and hear from some extremely reputable international guests. This...

Upcoming workshop for all nurses and health care professionals on Sunday 23rd September 8:30am-5pm at SkyCity Auckland Convention Centre.  Please click here for agenda and email eventagentnz@gmail.com to register!

Our great friends at the Unicorn Foundation (NET cancer patient advocate charity) are holding their annual NET Education Day on 22nd Sept 2018. Join us to hear from international and local NET experts and we allow plenty of time to connect with other NET patients...

Dr Ben Lawrence, one of the NETwork! Principle Investigators, and a number of close collaborators were involved in a multidisciplinary panel made up of international experts for developing these recently published guidelines.  These guidelines are now actively...

One month to go until NZSO 2018 in Queenstown!  We are very excited to have Dr Kate Parker presenting our work on Merkel Cell Polyomavirus status and outcome for MCC in NZ, Tamsin Robb presenting the early stages of our tumour evolution study, as well as Sandra...